{"title":"回复:“额肌瓣与最大前提肌切除术作为重度先天性上睑下垂患者的首选”。","authors":"R. Medel, L. Vasquez, J. C. Sánchez España","doi":"10.1097/IOP.0000000000001367","DOIUrl":null,"url":null,"abstract":"To the Editor: I thank Dr. Putterman for his comments on our recent publication. For me it is a pride that he has read our work and took the time to make suggestions, which I appreciate and respect. As he commented, we have a relatively large percentage of reoperations, about 50% of 24 patients treated with super maximum resection/Whitnall sling. Keep in mind that this reoperation result is after a follow up of 10 years, and as we understand Dr. Putterman’s fantastic work, of 8 patients in the group of super maximum resection associating a Tarsectomy (T) (Table 4, group I), only 1 patient required reoperation according his criteria. But based on our criteria, 4 patients would have required reoperation (2.5, 2.5, 3, 2 mm of postoperative ptosis), which means half of the patients of the entire group (just like our 50% of revision surgery in our work). Nevertheless, we could not see the evolution in time of the patients in Dr. Putterman’s study, and to have a good comparison of both techniques/groups, it would be interesting to have similar follow-up times. Another difference in our study is that all 71 cases were operated on with an age younger than 2 years old. In Dr. Putterman’s work, we only can find 2 cases younger than 2 years old and these were included in the non-Tarsectomy group (Table 4, group II). I want to thank Dr. Putterman for the recommendation to perform a Tarsectomy associated with super maximum resection. This is a valuable contribution to the ptosis surgeon community. The aim of our study was just to evaluate the reoperation rate of a new technique (frontalis muscle flap) with a wellknown technique (super maximum resection) under the same conditions (same surgeon, same reoperation criteria) and in a homogenous age group of patients. I believe the technique we developed for frontalis muscle flap, in appropriate hands, is safer with less morbidity, less complications, and less reoperation rates than any other technique for patients with severe congenital ptosis having very poor levator muscle function. I appreciate again the cordial suggestion and wish to thank Dr. Putterman for his invaluable contributions to ptosis surgery. I am willing to respond to any new concerns regarding this issue. Ramón Medel, MD. Luz María Vasquez, M.D. Juan Carlos Sánchez España, M.D., Ph.D.","PeriodicalId":19621,"journal":{"name":"Ophthalmic Plastic & Reconstructive Surgery","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reply re: \\\"Frontalis Muscle Flap Versus Maximum Anterior Levator Resection as the First Option for Patients With Severe Congenital Ptosis\\\".\",\"authors\":\"R. Medel, L. Vasquez, J. C. Sánchez España\",\"doi\":\"10.1097/IOP.0000000000001367\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To the Editor: I thank Dr. Putterman for his comments on our recent publication. For me it is a pride that he has read our work and took the time to make suggestions, which I appreciate and respect. As he commented, we have a relatively large percentage of reoperations, about 50% of 24 patients treated with super maximum resection/Whitnall sling. Keep in mind that this reoperation result is after a follow up of 10 years, and as we understand Dr. Putterman’s fantastic work, of 8 patients in the group of super maximum resection associating a Tarsectomy (T) (Table 4, group I), only 1 patient required reoperation according his criteria. But based on our criteria, 4 patients would have required reoperation (2.5, 2.5, 3, 2 mm of postoperative ptosis), which means half of the patients of the entire group (just like our 50% of revision surgery in our work). Nevertheless, we could not see the evolution in time of the patients in Dr. Putterman’s study, and to have a good comparison of both techniques/groups, it would be interesting to have similar follow-up times. Another difference in our study is that all 71 cases were operated on with an age younger than 2 years old. In Dr. Putterman’s work, we only can find 2 cases younger than 2 years old and these were included in the non-Tarsectomy group (Table 4, group II). I want to thank Dr. Putterman for the recommendation to perform a Tarsectomy associated with super maximum resection. This is a valuable contribution to the ptosis surgeon community. The aim of our study was just to evaluate the reoperation rate of a new technique (frontalis muscle flap) with a wellknown technique (super maximum resection) under the same conditions (same surgeon, same reoperation criteria) and in a homogenous age group of patients. I believe the technique we developed for frontalis muscle flap, in appropriate hands, is safer with less morbidity, less complications, and less reoperation rates than any other technique for patients with severe congenital ptosis having very poor levator muscle function. I appreciate again the cordial suggestion and wish to thank Dr. Putterman for his invaluable contributions to ptosis surgery. I am willing to respond to any new concerns regarding this issue. Ramón Medel, MD. Luz María Vasquez, M.D. Juan Carlos Sánchez España, M.D., Ph.D.\",\"PeriodicalId\":19621,\"journal\":{\"name\":\"Ophthalmic Plastic & Reconstructive Surgery\",\"volume\":\"19 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic Plastic & Reconstructive Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/IOP.0000000000001367\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic Plastic & Reconstructive Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/IOP.0000000000001367","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
致编辑:我感谢Putterman博士对我们最近出版的文章的评论。对我来说,他阅读了我们的工作并花时间提出建议是一种骄傲,我对此表示赞赏和尊重。正如他所说,我们的再手术比例相对较高,24例患者中约有50%接受了超级最大切除/Whitnall吊带手术。请记住,这个再手术的结果是在10年的随访之后,正如我们所理解的Putterman博士的出色工作,在超级最大切除联合跗骨切除术(T)组的8名患者中(表4,组I),根据他的标准,只有1名患者需要再手术。但根据我们的标准,4例患者需要再次手术(术后上睑下垂2.5、2.5、3、2 mm),这意味着整个组的一半患者(就像我们工作中50%的翻修手术)。然而,在Putterman博士的研究中,我们无法看到患者在时间上的变化,为了对两种技术/组进行很好的比较,如果有类似的随访时间将会很有趣。本研究的另一个不同之处在于,所有71例患者的手术年龄都小于2岁。在Putterman博士的工作中,我们只发现了2例小于2岁的病例,这些病例被纳入了非跗骨切除术组(表4,II组)。我要感谢Putterman博士建议进行跗骨切除术并进行超最大切除术。这是对上睑下垂外科社区的一个有价值的贡献。我们研究的目的只是在相同的条件下(相同的外科医生,相同的再手术标准),在相同的年龄组患者中,评估一种新技术(额肌瓣)与一种知名技术(超级最大切除)的再手术率。我相信我们开发的额肌瓣技术,在适当的情况下,比其他任何技术更安全,发病率更低,并发症更少,再手术率也更低对于重度先天性上睑下垂提上睑肌功能很差的患者。我再次感谢他的诚恳建议,并感谢Putterman医生对上睑下垂手术的宝贵贡献。我愿意对有关这个问题的任何新的关切作出回应。Ramón Medel, MD, Luz María Vasquez, M.D., Juan Carlos Sánchez España, M.D., Ph.D。
Reply re: "Frontalis Muscle Flap Versus Maximum Anterior Levator Resection as the First Option for Patients With Severe Congenital Ptosis".
To the Editor: I thank Dr. Putterman for his comments on our recent publication. For me it is a pride that he has read our work and took the time to make suggestions, which I appreciate and respect. As he commented, we have a relatively large percentage of reoperations, about 50% of 24 patients treated with super maximum resection/Whitnall sling. Keep in mind that this reoperation result is after a follow up of 10 years, and as we understand Dr. Putterman’s fantastic work, of 8 patients in the group of super maximum resection associating a Tarsectomy (T) (Table 4, group I), only 1 patient required reoperation according his criteria. But based on our criteria, 4 patients would have required reoperation (2.5, 2.5, 3, 2 mm of postoperative ptosis), which means half of the patients of the entire group (just like our 50% of revision surgery in our work). Nevertheless, we could not see the evolution in time of the patients in Dr. Putterman’s study, and to have a good comparison of both techniques/groups, it would be interesting to have similar follow-up times. Another difference in our study is that all 71 cases were operated on with an age younger than 2 years old. In Dr. Putterman’s work, we only can find 2 cases younger than 2 years old and these were included in the non-Tarsectomy group (Table 4, group II). I want to thank Dr. Putterman for the recommendation to perform a Tarsectomy associated with super maximum resection. This is a valuable contribution to the ptosis surgeon community. The aim of our study was just to evaluate the reoperation rate of a new technique (frontalis muscle flap) with a wellknown technique (super maximum resection) under the same conditions (same surgeon, same reoperation criteria) and in a homogenous age group of patients. I believe the technique we developed for frontalis muscle flap, in appropriate hands, is safer with less morbidity, less complications, and less reoperation rates than any other technique for patients with severe congenital ptosis having very poor levator muscle function. I appreciate again the cordial suggestion and wish to thank Dr. Putterman for his invaluable contributions to ptosis surgery. I am willing to respond to any new concerns regarding this issue. Ramón Medel, MD. Luz María Vasquez, M.D. Juan Carlos Sánchez España, M.D., Ph.D.